Correlation Between Antibiotice and Compa Sibiu

Can any of the company-specific risk be diversified away by investing in both Antibiotice and Compa Sibiu at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Antibiotice and Compa Sibiu into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Antibiotice Ia and Compa Sibiu, you can compare the effects of market volatilities on Antibiotice and Compa Sibiu and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Antibiotice with a short position of Compa Sibiu. Check out your portfolio center. Please also check ongoing floating volatility patterns of Antibiotice and Compa Sibiu.

Diversification Opportunities for Antibiotice and Compa Sibiu

0.62

Correlation Coefficient

Antibiotice  Compa Sibiu

Poor diversification

The 3 months correlation between Antibiotice and Compa is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Antibiotice Ia and Compa Sibiu in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Compa Sibiu and Antibiotice is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Antibiotice Ia are associated (or correlated) with Compa Sibiu. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Compa Sibiu has no effect on the direction of Antibiotice i.e., Antibiotice and Compa Sibiu go up and down completely randomly.

Pair Corralation between Antibiotice and Compa Sibiu

Assuming the 90 days trading horizon Antibiotice Ia is expected to under-perform the Compa Sibiu. But the stock apears to be less risky and, when comparing its historical volatility, Antibiotice Ia is 1.73 times less risky than Compa Sibiu. The stock trades about -0.18 of its potential returns per unit of risk. The Compa Sibiu is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest  53.00  in Compa Sibiu on December 30, 2024 and sell it today you would lose (2.00) from holding Compa Sibiu or give up 3.77% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Antibiotice Ia  vs.  Compa Sibiu

Antibiotice Ia

Risk-Adjusted Performance

Very Weak

Over the last 90 days Antibiotice Ia has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's fundamental drivers remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Compa Sibiu

Risk-Adjusted Performance

Very Weak

Over the last 90 days Compa Sibiu has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Compa Sibiu is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Antibiotice and Compa Sibiu

The main advantage of trading using opposite Antibiotice and Compa Sibiu positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Antibiotice position performs unexpectedly, Compa Sibiu can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Compa Sibiu will offset losses from the drop in Compa Sibiu's long position.

The idea behind Antibiotice Ia and Compa Sibiu pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.